This study presents increased blood lithium concentration after the initiation of the concomitant therapy of lithium and propranolol, which is a beta-blocker drug, due to the complaint of tremor causing functional impairment.
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Lithium is used in the treatment for many psychiatric disorders, like bipolar d isorder, schizoaffective disorder and depression.
📊
Key Findings & Data:Lithium has a very narrow therapeutic range and there are many reasons that increase the blood levels of lithium.
💡
Conclusion & Impact:This study presents increased blood lithium concentration after the initiation of the concomitant therapy of lithium and propranolol, which is a beta-blocker drug, due to the complaint of tremor causing functional impairment.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters
Abstract
Lithium is used in the treatment for many psychiatric disorders, like bipolar d isorder, schizoaffective disorder and depression. Lithium has a very narrow therapeutic range and there are many reasons that increase the blood levels of lithium. Combining lithium with other medications with the aim of reducing side effects or supporting the therapy may result in substantial elevations in lithium concentrations and may lead to signs of intoxication. This study presents increased blood lithium concentration after the initiation of the concomitant therapy of lithium and propranolol, which is a beta-blocker drug, due to the complaint of tremor causing functional impairment.
🔖
Cite This Article
AKYÜZ, E. F. Ç., ÇEÇEN, H. (2018). Elevated blood lithium concentration following concomitant lithium and propranolol therapy: A case report. Eastern Journal of Medicine, Cilt: 23 - Sayı: 2, 124–127. https://ajindex.com/articles/195867
References (10)
Shine B, McKnight RF, Leaver L, Geddes JR. Long-term effects of lithium on renal, thyroid, and parathyroid function: a retrospective analysis of laboratory data. Lancet 2015; 386: 461-468
Aral H, Vecchio-Sadus A. Toxicity of lithium to humans and the environment- A literature review. Ecotoxicol Environ Saf 2008; 70: 349- 356
Lenox RH, McNamara RK, Papke RL, Manji HK. Neurobiology of lithium: An update. J Clin Psychiatry 1998; 58: 37-47
Conley D, Coyne M, Chung A, Bonorris G, Schoenfield L. Propranolol inhibits adenylate cyclase and secretion stimulated by deoxycholic acid in the rabbit colon. Gastroenterology 1976; 71: 72-75
Shand DG. Pharmacokinetics of propranolol: a review. Postgrad Med J 1976; 52: 22-25
Laragh JH, Bühler FR. Propranolol, renin and hypertension: a review. Postgrad Med J 1976; 52: 109-115
Bahalı K, Gülçelik G, Fettahoğlu Ç, et al. (Çev). Duygudurum Düzenleyiciler. Avcı A, Yolga Tahiroğlu A (Çev Edit.). Çocuk ve ergenlerde psikotropik ilaç kullanımı & Klinik El Kitabı. Bezchlıbnyk KZ, Vıranı BAS (eds). Adana Nobel Kitabevi, Adana, 2010. s: 198-230.